Development of a current Good Manufacturing Practice-compliant Process for Producing Cryptosporidium parvum oocysts for Clinical Use.
Saved in:
| Title: | Development of a current Good Manufacturing Practice-compliant Process for Producing Cryptosporidium parvum oocysts for Clinical Use. |
|---|---|
| Authors: | Jumani RS; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Thomas B; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Lakshman J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Ostermeier C; Novartis Pharmaceuticals Corporation, Basel, Switzerland., Nuber N; Novartis Pharmaceuticals Corporation, Basel, Switzerland., Blusch JH; Novartis Pharmaceuticals Corporation, Basel, Switzerland., Braud-Perez S; Novartis Pharmaceuticals Corporation, Basel, Switzerland., Wetty D; Novartis Pharmaceuticals Corporation, Cambridge, Massachusetts, USA., Nouaime L; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Dederichs J; Novartis Pharmaceuticals Corporation, Basel, Switzerland., Etse J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Grubesic S; Novartis Pharmaceuticals Corporation, Basel, Switzerland., Lakshminarayana SB; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Watson LC; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Blais J; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Thompson Z; Charles River Laboratories, Biological Testing Solutions, Wayne, Pennsylvania, USA., Jaber TZ; Charles River Laboratories, Biological Testing Solutions, Wayne, Pennsylvania, USA., Jones MR; Charles River Laboratories, Biological Testing Solutions, Wayne, Pennsylvania, USA., Schaefer DA; School of Animal and Comparative Biomedical Sciences, The University of Arizona, Tucson, Arizona, USA., Riggs MW; School of Animal and Comparative Biomedical Sciences, The University of Arizona, Tucson, Arizona, USA., Huston CD; Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, USA., Diagana TT; Global Health, Biomedical Research, Novartis, Emeryville, California, USA., Manjunatha UH; Global Health, Biomedical Research, Novartis, Emeryville, California, USA. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2026 Feb 18. Date of Electronic Publication: 2026 Feb 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41707104 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of a current Good Manufacturing Practice-compliant Process for Producing Cryptosporidium parvum oocysts for Clinical Use. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Jumani+RS%22">Jumani RS</searchLink>; Global Health, Biomedical Research, Novartis, Emeryville, California, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+B%22">Thomas B</searchLink>; Global Health, Biomedical Research, Novartis, Emeryville, California, USA.<br /><searchLink fieldCode="AU" term="%22Lakshman+J%22">Lakshman J</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Ostermeier+C%22">Ostermeier C</searchLink>; Novartis Pharmaceuticals Corporation, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Nuber+N%22">Nuber N</searchLink>; Novartis Pharmaceuticals Corporation, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Blusch+JH%22">Blusch JH</searchLink>; Novartis Pharmaceuticals Corporation, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Braud-Perez+S%22">Braud-Perez S</searchLink>; Novartis Pharmaceuticals Corporation, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wetty+D%22">Wetty D</searchLink>; Novartis Pharmaceuticals Corporation, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Nouaime+L%22">Nouaime L</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Dederichs+J%22">Dederichs J</searchLink>; Novartis Pharmaceuticals Corporation, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Etse+J%22">Etse J</searchLink>; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Grubesic+S%22">Grubesic S</searchLink>; Novartis Pharmaceuticals Corporation, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lakshminarayana+SB%22">Lakshminarayana SB</searchLink>; Global Health, Biomedical Research, Novartis, Emeryville, California, USA.<br /><searchLink fieldCode="AU" term="%22Watson+LC%22">Watson LC</searchLink>; Global Health, Biomedical Research, Novartis, Emeryville, California, USA.<br /><searchLink fieldCode="AU" term="%22Blais+J%22">Blais J</searchLink>; Global Health, Biomedical Research, Novartis, Emeryville, California, USA.<br /><searchLink fieldCode="AU" term="%22Thompson+Z%22">Thompson Z</searchLink>; Charles River Laboratories, Biological Testing Solutions, Wayne, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Jaber+TZ%22">Jaber TZ</searchLink>; Charles River Laboratories, Biological Testing Solutions, Wayne, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Jones+MR%22">Jones MR</searchLink>; Charles River Laboratories, Biological Testing Solutions, Wayne, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Schaefer+DA%22">Schaefer DA</searchLink>; School of Animal and Comparative Biomedical Sciences, The University of Arizona, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Riggs+MW%22">Riggs MW</searchLink>; School of Animal and Comparative Biomedical Sciences, The University of Arizona, Tucson, Arizona, USA.<br /><searchLink fieldCode="AU" term="%22Huston+CD%22">Huston CD</searchLink>; Department of Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, USA.<br /><searchLink fieldCode="AU" term="%22Diagana+TT%22">Diagana TT</searchLink>; Global Health, Biomedical Research, Novartis, Emeryville, California, USA.<br /><searchLink fieldCode="AU" term="%22Manjunatha+UH%22">Manjunatha UH</searchLink>; Global Health, Biomedical Research, Novartis, Emeryville, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2026 Feb 18. <i>Date of Electronic Publication: </i>2026 Feb 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41707104 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiag107 Languages: – Code: eng Text: English Titles: – TitleFull: Development of a current Good Manufacturing Practice-compliant Process for Producing Cryptosporidium parvum oocysts for Clinical Use. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Jumani RS – PersonEntity: Name: NameFull: Thomas B – PersonEntity: Name: NameFull: Lakshman J – PersonEntity: Name: NameFull: Ostermeier C – PersonEntity: Name: NameFull: Nuber N – PersonEntity: Name: NameFull: Blusch JH – PersonEntity: Name: NameFull: Braud-Perez S – PersonEntity: Name: NameFull: Wetty D – PersonEntity: Name: NameFull: Nouaime L – PersonEntity: Name: NameFull: Dederichs J – PersonEntity: Name: NameFull: Etse J – PersonEntity: Name: NameFull: Grubesic S – PersonEntity: Name: NameFull: Lakshminarayana SB – PersonEntity: Name: NameFull: Watson LC – PersonEntity: Name: NameFull: Blais J – PersonEntity: Name: NameFull: Thompson Z – PersonEntity: Name: NameFull: Jaber TZ – PersonEntity: Name: NameFull: Jones MR – PersonEntity: Name: NameFull: Schaefer DA – PersonEntity: Name: NameFull: Riggs MW – PersonEntity: Name: NameFull: Huston CD – PersonEntity: Name: NameFull: Diagana TT – PersonEntity: Name: NameFull: Manjunatha UH IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 02 Text: 2026 Feb 18 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1537-6613 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |